OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3 Reasons to Forget Teladoc Health Stock
Uncategorized

3 Reasons to Forget Teladoc Health Stock

January 4, 2026

The stock is far too risky.

December jobs numbers get data back on track during first full week of trading in 2026: What to watch
Uncategorized

December jobs numbers get data back on track during first full week of trading in 2026: What to watch

January 4, 2026

Investors will start the first full week of 2026 watching to see if the market can post positive returns for the “Santa Claus rally” period, with...

A Once-in-a-Decade Investment Opportunity: The 3 Best AI Stocks to Buy in January 2026
Uncategorized

A Once-in-a-Decade Investment Opportunity: The 3 Best AI Stocks to Buy in January 2026

January 4, 2026

Wall Street analysts forecast significant upside in these artificial intelligence stocks in the new year.

Dow Jones Futures Set To React To Trump’s Venezuela Action; Nvidia, AMD, Taiwan Semi Due
Uncategorized

Dow Jones Futures Set To React To Trump’s Venezuela Action; Nvidia, AMD, Taiwan Semi Due

January 3, 2026

President Trump said the U.S. will “run” Venezuela after capturing Nicolas Maduro. How will markets react? Nvidia, AMD will headline CES this week.

Why Was It Mark Cuban Who Took On Big Pharma? ‘I’m Rich As F*** And I Didn’t Care About The Money’
Uncategorized

Why Was It Mark Cuban Who Took On Big Pharma? ‘I’m Rich As F*** And I Didn’t Care About The Money’

January 3, 2026

Mark Cuban said that the reason he took on big pharma with his online pharmacy Cost Plus Drugs was that he could. “I’m rich as f*** and I didn’t care about the...

3rdPartyFeeds

Nvidia Just Made a Major Move for 2026. Time to Buy?

January 3, 2026

Nvidia makes the world's most powerful AI chips. Read More...

AI debt spree is fueling a credit trading frenzy
Uncategorized

AI debt spree is fueling a credit trading frenzy

January 3, 2026

An average of $50 billion in investment-grade and high-yield bonds changed hands each trading day last year, according to Crisil Coalition Greenwich, a...

3rdPartyFeeds

Cathie Wood’s ARK Fintech ETF Defies Industry Downturn, Soaring 30% In 2025

January 3, 2026

Cathie Wood’s ARK Blockchain & Fintech Innovation ETF (ARKF) outperformed the industry slump in 2025, delivering a remarkable 29% return The ETF’s...

Dow Jones Futures: Trump Says U.S. To ‘Run’ Venezuela After Capturing Maduro; Nvidia, AMD, Taiwan Semi Due
Uncategorized

Dow Jones Futures: Trump Says U.S. To ‘Run’ Venezuela After Capturing Maduro; Nvidia, AMD, Taiwan Semi Due

January 3, 2026

President Donald Trump said the U.S. has captured Venezuela leader Nicolas Maduro. Nvidia and AMD are CES headliners this coming week.

3 Consumer Stocks Set for a Comeback in 2026
Uncategorized

3 Consumer Stocks Set for a Comeback in 2026

January 3, 2026

After massive sell-offs, these stocks appear set to begin their recoveries.

Previous 1 … 65 66 67 68 69 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.